Drug industry, AARP fight over Medicare changes

Published May 10, 2016 4:01am ET



The biggest lobbyists for seniors and the pharmaceutical industry are fighting over an experiment to drastically reform how Medicare pays doctors.

AARP, the biggest senior lobbying group, said Monday it supports the Obama administration’s experiment to overhaul the payment model for Medicare Part B to ensure doctors prescribe cheaper drugs to patients. The proposal has received significant pushback from the pharmaceutical industry, cancer patient advocacy groups and many Republican lawmakers.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.